Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B cell malignancies.
Andres ChangJean L KoffLilin LaiVictor Manuel Orellana-NoiaMinal SuratiAlyssa LealMadison Leigh EllisBushra WaliAlberto MorenoSusanne L LindermanColin B O'LearyPamela Blair AllenMichael C ChurnetskiMadhav V DhodapkarMehul S SutharJonathon B CohenRajesh M ValanparambilPublished in: Blood advances (2023)